MASS

8.7606.51%
FM

Fenel M. Eloi

Independent Non-Employee Director

Mr. Fenel M. Eloi, M.B.A., is Member of Scientific Advisory Board of Mitotherapeutix, LLC. He serves as Independent Non-Employee Director of Standard BioTools Inc. since March 2023. Mr. Eloi has served as Managing Partner of P&M Capital Partners, LLC since April 2018. He is Board Member at VIC Technology Venture Development, LLC. He has been an Independent Director at Ultivue, Inc. since August 2021 and 908 Devices Inc. since February 23, 2021. He is Director of Cellia Science, Inc. He serves as a Director of Vaxess Technologies Inc. and VIC Technology Venture Development. Mr. Eloi served as Chief Operating Officer at Cell Signaling Technology, Inc. from September 2005 to March 2018 and served as its Chief Financial Officer and Director. He also serves on the Board of Directors of MitoTherapeutix. Mr. Eloi served as Chief Operating Officer and Chief Financial Officer at Interleukin Genetics Inc. from June 2000 to August 15, 2005. He also served as Principal Accounting Officer, Treasurer and Secretary of Interleukin Genetics Inc. until August 15, 2005. Prior to joining Interleukin Genetics Inc. Mr. Eloi served as Senior Vice President and Chief Financial Officer for LifeCell Corporation since 1999. Before joining LifeCell, Mr. Eloi served at Genome Therapeutics Corporation, where he served as Senior Vice President and Chief Financial Officer from 1991 to 1999 and Corporate Controller from 1989 to 1991. From 1984 to 1989, Mr. Eloi served as a Business Unit Financial Manager at GTE Verizon Corporation. He also held various positions at Haemonetics Corporation and Simplex Corporation. He was a Director of BioHelix Corporation. Mr. Eloi has an MBA from Anna Maria College in Paxton, Massachusetts, as well as a BS and BA in Business and Finance from Lee University in Cleveland, Tennessee.

公司职务